Perfil
Sascha Bucher is currently an Independent Non-Executive Director at Tarsier Pharma Ltd. since 2018 and Head-Global Transactions at Roivant Sciences GmbH.
Former positions include Director at Sumitomo Pharma Switzerland GmbH and Deputy Head-Global M&A at Roche Holding AG from 2009 to 2016.
Education includes an MBA from Harvard Business School.
Cargos activos de Sascha Bucher
| Empresas | Cargo | Inicio |
|---|---|---|
Roivant Sciences GmbH
Roivant Sciences GmbH Pharmaceuticals: MajorHealth Technology Develops and markets biopharmaceutical products | Corporate Officer/Principal | - |
Tarsier Pharma Ltd.
Tarsier Pharma Ltd. Pharmaceuticals: MajorHealth Technology Operates as a clinical-stage company that develops and commercializes novel therapeutic treatments for autoimmune eye disease & inflammatory ocular diseases | Director/Miembro de la Junta | 01/01/2018 |
Antiguos cargos conocidos de Sascha Bucher.
| Empresas | Cargo | Fin |
|---|---|---|
| ROCHE HOLDING AG | Corporate Officer/Principal | 01/01/2016 |
Myovant Sciences GmbH
Myovant Sciences GmbH BiotechnologyHealth Technology Engages in development and marketing of biopharmaceutical products | Corporate Officer/Principal | - |
Formación de Sascha Bucher.
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
| Empresas privadas | 5 |
|---|---|
Roche Holding AG
Roche Holding AG Pharmaceuticals: MajorHealth Technology Operates as a research-focused healthcare company with combined focus in pharmaceuticals and diagnostics | Health Technology |
Harvard Business School
Harvard Business School Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Roivant Sciences GmbH
Roivant Sciences GmbH Pharmaceuticals: MajorHealth Technology Develops and markets biopharmaceutical products | Health Technology |
Myovant Sciences GmbH
Myovant Sciences GmbH BiotechnologyHealth Technology Engages in development and marketing of biopharmaceutical products | Health Technology |
Tarsier Pharma Ltd.
Tarsier Pharma Ltd. Pharmaceuticals: MajorHealth Technology Operates as a clinical-stage company that develops and commercializes novel therapeutic treatments for autoimmune eye disease & inflammatory ocular diseases | Health Technology |
- Bolsa de valores
- Insiders
- Sascha Bucher
















